Vimarsana
Biggest News Aggregation in the World

Page 20 - Sackler Faculty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sackler Faculty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sackler Faculty Today - Breaking & Trending Today

Israeli Artificial Intelligence Identifies Risk Factors For Blood Infection - Vimarsana News

Israeli Artificial Intelligence Identifies Risk Factors For Blood Infection

'The algorithm was able to find patterns that surprised us, parameters in the blood that we hadn’t even thought about taking into account.'

Saving Lives With Artificial Intelligence - Vimarsana News

Saving Lives With Artificial Intelligence

A new technology developed at Tel Aviv University will make it possible, using artificial intelligence, to identify patients who are at risk of serious

Saving lives with artificial intelligence » J-Wire - Vimarsana News

Saving lives with artificial intelligence » J-Wire

New artificial intelligence technology developed at Tel Aviv University will make it possible to identify patients at risk of serious illness as a result of blood infections. Researchers trained the AI program to study the electronic medical records of about 8,000 patients at Tel Aviv’s Ichilov Hospital who were found to be positive for blood…

New South African variant worries Israel, world - here's what we know - Vimarsana News

New South African variant worries Israel, world - here's what we know

The South African coronavirus variant known as Omicron or B.1.1.529 is raising red flags worldwide. 

Source: jpost.com
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years | Vaccination | JAMA - Vimarsana News

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years | Vaccination | JAMA

This study assesses antispike (anti-S) IgG antibody titers before and after a third BNT162b2 dose (booster) in individuals aged 60 years and older in Israel.